Multivariable analysis of time from diagnosis to the first treatment
| Characteristic . | Category . | HR (95% CI) . | P . |
|---|---|---|---|
| RAI stage | 0 | Baseline | .0025 |
| I-IV | 2.75 (1.43-5.31) | ||
| Cytogenetics | del 13q | Baseline | .001 |
| Diploid | 1.69 (1.05-2.75) | ||
| Trisomy 12q | 1.41 (0.78-2.56) | ||
| del 11q | 2.36 (1.44-3.86) | ||
| del 17p | 2.38 (1.35-4.20) | ||
| CD38 | Negative | Baseline | .023 |
| Positive | 1.43 (1.0-2.05) | ||
| CCL3, pg/mL | Low (< 10) | Baseline | < .0001 |
| High (≥ 10) | 2.33 (1.56-3.46) |
| Characteristic . | Category . | HR (95% CI) . | P . |
|---|---|---|---|
| RAI stage | 0 | Baseline | .0025 |
| I-IV | 2.75 (1.43-5.31) | ||
| Cytogenetics | del 13q | Baseline | .001 |
| Diploid | 1.69 (1.05-2.75) | ||
| Trisomy 12q | 1.41 (0.78-2.56) | ||
| del 11q | 2.36 (1.44-3.86) | ||
| del 17p | 2.38 (1.35-4.20) | ||
| CD38 | Negative | Baseline | .023 |
| Positive | 1.43 (1.0-2.05) | ||
| CCL3, pg/mL | Low (< 10) | Baseline | < .0001 |
| High (≥ 10) | 2.33 (1.56-3.46) |